再卖资产!药明康德出售药明合联7.17%股权,回笼资金24.26 亿港元

第一财经
13 Jan

继宣布出售美国以及英国细胞业务外,药明康德(603259.SH、02359.HK)又处理了另外一项资产。1月13日傍晚,药明康德发布公告称,2024年11月8日及2025年1月10日,通过两次大宗交易,公司累计出售药明合联(02268.HK)8600万股股票,约占药明合联当前总股本的7.17%,累计成交金额约24.26亿港元(不包含手续费等交易费用),占公司最近一期(2023年度)经审计归属母公司...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10